Astrazeneca Plc Adr Stock Current Asset

AZN Stock  USD 67.75  0.51  0.75%   
AstraZeneca PLC ADR fundamentals help investors to digest information that contributes to AstraZeneca PLC's financial success or failures. It also enables traders to predict the movement of AstraZeneca Stock. The fundamental analysis module provides a way to measure AstraZeneca PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AstraZeneca PLC stock.
As of the 28th of March 2024, Non Current Assets Total is likely to grow to about 79.9 B, while Total Current Assets are likely to drop about 15.3 B.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

AstraZeneca Current Asset Analysis

AstraZeneca PLC's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
 2021 2022 2023 2024 (projected)
Interest Expense1.3B1.3B1.6B1.7B
Depreciation And Amortization6.5B5.6B4.9B5.2B

Current Asset

 = 

Cash

+

Deposits

+

Liquid Assets

More About Current Asset | All Equity Analysis

Current AstraZeneca PLC Current Asset

    
  16.01 B  
Most of AstraZeneca PLC's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AstraZeneca PLC ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

AstraZeneca Current Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for AstraZeneca PLC is extremely important. It helps to project a fair market value of AstraZeneca Stock properly, considering its historical fundamentals such as Current Asset. Since AstraZeneca PLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of AstraZeneca PLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of AstraZeneca PLC's interrelated accounts and indicators.
0.340.90.85-0.380.3-0.360.960.690.790.930.740.910.960.430.791.0-0.190.830.50.83-0.660.69-0.360.60.680.630.80.090.85
0.340.40.120.22-0.580.070.250.140.450.39-0.080.140.27-0.02-0.10.350.00.01-0.270.19-0.05-0.120.08-0.040.3-0.20.08-0.590.19
0.90.40.65-0.20.11-0.220.740.760.750.970.690.70.820.080.570.91-0.060.650.470.8-0.30.410.010.260.480.510.84-0.040.87
0.850.120.65-0.780.23-0.530.890.340.730.790.650.910.90.480.810.86-0.440.870.610.86-0.830.84-0.460.820.830.70.810.150.86
-0.380.22-0.2-0.78-0.030.6-0.470.13-0.47-0.37-0.35-0.58-0.49-0.23-0.49-0.410.63-0.62-0.68-0.690.63-0.720.33-0.68-0.69-0.65-0.59-0.12-0.65
0.3-0.580.110.23-0.03-0.060.40.44-0.050.120.510.330.320.530.620.280.320.360.10.0-0.390.42-0.490.360.010.310.150.650.05
-0.360.07-0.22-0.530.6-0.06-0.420.1-0.28-0.32-0.22-0.39-0.47-0.3-0.4-0.360.48-0.39-0.44-0.490.44-0.490.36-0.41-0.43-0.44-0.43-0.09-0.46
0.960.250.740.89-0.470.4-0.420.580.730.810.690.950.960.620.860.95-0.270.860.480.77-0.820.82-0.570.760.740.660.70.170.75
0.690.140.760.340.130.440.10.580.420.650.810.560.550.150.630.670.180.630.30.46-0.120.39-0.010.240.330.530.590.250.5
0.790.450.750.73-0.47-0.05-0.280.730.420.810.530.710.760.130.460.82-0.110.660.50.8-0.50.58-0.10.480.680.560.7-0.410.8
0.930.390.970.79-0.370.12-0.320.810.650.810.710.760.90.190.650.95-0.110.710.460.83-0.470.51-0.110.410.60.530.9-0.020.92
0.74-0.080.690.65-0.350.51-0.220.690.810.530.710.680.720.380.870.74-0.020.860.480.62-0.470.72-0.250.590.540.770.810.270.68
0.910.140.70.91-0.580.33-0.390.950.560.710.760.680.880.470.830.89-0.430.920.650.85-0.750.86-0.440.780.820.770.730.230.8
0.960.270.820.9-0.490.32-0.470.960.550.760.90.720.880.560.820.97-0.220.810.460.79-0.780.73-0.470.680.660.590.80.110.83
0.43-0.020.080.48-0.230.53-0.30.620.150.130.190.380.470.560.660.42-0.130.45-0.050.1-0.830.61-0.930.680.30.240.140.340.09
0.79-0.10.570.81-0.490.62-0.40.860.630.460.650.870.830.820.660.78-0.190.90.450.61-0.770.86-0.560.830.670.740.710.450.63
1.00.350.910.86-0.410.28-0.360.950.670.820.950.740.890.970.420.78-0.170.820.50.84-0.660.69-0.350.590.680.630.820.040.87
-0.190.0-0.06-0.440.630.320.48-0.270.18-0.11-0.11-0.02-0.43-0.22-0.13-0.19-0.17-0.4-0.61-0.530.31-0.450.22-0.4-0.49-0.48-0.28-0.17-0.38
0.830.010.650.87-0.620.36-0.390.860.630.660.710.860.920.810.450.90.82-0.40.690.82-0.690.93-0.40.830.830.910.80.240.78
0.5-0.270.470.61-0.680.1-0.440.480.30.50.460.480.650.46-0.050.450.5-0.610.690.83-0.280.65-0.020.430.520.860.660.120.74
0.830.190.80.86-0.690.0-0.490.770.460.80.830.620.850.790.10.610.84-0.530.820.83-0.490.71-0.130.540.770.810.87-0.020.96
-0.66-0.05-0.3-0.830.63-0.390.44-0.82-0.12-0.5-0.47-0.47-0.75-0.78-0.83-0.77-0.660.31-0.69-0.28-0.49-0.810.8-0.89-0.64-0.47-0.44-0.2-0.48
0.69-0.120.410.84-0.720.42-0.490.820.390.580.510.720.860.730.610.860.69-0.450.930.650.71-0.81-0.610.910.80.880.620.230.63
-0.360.080.01-0.460.33-0.490.36-0.57-0.01-0.1-0.11-0.25-0.44-0.47-0.93-0.56-0.350.22-0.4-0.02-0.130.8-0.61-0.61-0.32-0.25-0.07-0.33-0.08
0.6-0.040.260.82-0.680.36-0.410.760.240.480.410.590.780.680.680.830.59-0.40.830.430.54-0.890.91-0.610.790.680.480.210.48
0.680.30.480.83-0.690.01-0.430.740.330.680.60.540.820.660.30.670.68-0.490.830.520.77-0.640.8-0.320.790.710.610.020.69
0.63-0.20.510.7-0.650.31-0.440.660.530.560.530.770.770.590.240.740.63-0.480.910.860.81-0.470.88-0.250.680.710.720.190.72
0.80.080.840.81-0.590.15-0.430.70.590.70.90.810.730.80.140.710.82-0.280.80.660.87-0.440.62-0.070.480.610.720.130.95
0.09-0.59-0.040.15-0.120.65-0.090.170.25-0.41-0.020.270.230.110.340.450.04-0.170.240.12-0.02-0.20.23-0.330.210.020.190.130.02
0.850.190.870.86-0.650.05-0.460.750.50.80.920.680.80.830.090.630.87-0.380.780.740.96-0.480.63-0.080.480.690.720.950.02
Click cells to compare fundamentals
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Competition

AstraZeneca Total Assets

Total Assets

106.17 Billion

At this time, AstraZeneca PLC's Total Assets are very stable compared to the past year.
In accordance with the recently published financial statements, AstraZeneca PLC ADR has a Current Asset of 16.01 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current asset for all United States stocks is 71.42% lower than that of the firm.

AstraZeneca Current Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AstraZeneca PLC's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AstraZeneca PLC could also be used in its relative valuation, which is a method of valuing AstraZeneca PLC by comparing valuation metrics of similar companies.
AstraZeneca PLC is currently under evaluation in current asset category among related companies.

AstraZeneca Fundamentals

About AstraZeneca PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AstraZeneca PLC ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AstraZeneca PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AstraZeneca PLC ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Non Current Assets Total76.1 B79.9 B
Total Current Assets25.1 B15.3 B
Other Current Assets116 M110.2 M

AstraZeneca PLC Investors Sentiment

The influence of AstraZeneca PLC's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in AstraZeneca. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to AstraZeneca PLC's public news can be used to forecast risks associated with an investment in AstraZeneca. The trend in average sentiment can be used to explain how an investor holding AstraZeneca can time the market purely based on public headlines and social activities around AstraZeneca PLC ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
AstraZeneca PLC's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AstraZeneca PLC's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average AstraZeneca PLC's news discussions. The higher the estimated score, the more favorable is the investor's outlook on AstraZeneca PLC.

AstraZeneca PLC Implied Volatility

    
  21.4  
AstraZeneca PLC's implied volatility exposes the market's sentiment of AstraZeneca PLC ADR stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if AstraZeneca PLC's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that AstraZeneca PLC stock will not fluctuate a lot when AstraZeneca PLC's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AstraZeneca PLC in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AstraZeneca PLC's short interest history, or implied volatility extrapolated from AstraZeneca PLC options trading.

Pair Trading with AstraZeneca PLC

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AstraZeneca PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will appreciate offsetting losses from the drop in the long position's value.

Moving against AstraZeneca Stock

  0.48MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to AstraZeneca PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AstraZeneca PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AstraZeneca PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AstraZeneca PLC ADR to buy it.
The correlation of AstraZeneca PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AstraZeneca PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AstraZeneca PLC ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AstraZeneca PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:
Check out AstraZeneca PLC Piotroski F Score and AstraZeneca PLC Altman Z Score analysis.
Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for AstraZeneca Stock analysis

When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stocks Directory
Find actively traded stocks across global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.059
Dividend Share
2.9
Earnings Share
1.9
Revenue Per Share
2.4547
Quarterly Revenue Growth
0.073
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.